acebutolol has been researched along with Blood Loss, Surgical in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, H; Koo, CH; Ryu, JH; Shin, HJ | 1 |
| Auerbach, M; Farmer, SL; Frank, SM; Hardy, JF; Javidroozi, M; Leahy, MF; Meier, J; Ozawa, S; Shander, A | 1 |
| Hubert, L; Lasocki, S; Rineau, E; Samson, E; Stoyanov, A | 1 |
| Kim, HJ; Kim, SK; Seo, WY; Yoo, JJ | 1 |
| Froessler, B; Hodyl, NA; Murphy, EM; Palm, P; Singh, R; Weber, I | 1 |
1 review(s) available for acebutolol and Blood Loss, Surgical
| Article | Year |
|---|---|
The Effect of Perioperative Intravenous Iron on Hemoglobin in Surgical Patients: A Meta-Analysis.
Topics: Administration, Intravenous; Administration, Oral; Blood Loss, Surgical; Blood Transfusion; Ferric Compounds; Hemoglobins; Humans; Maltose; Perioperative Care; Postoperative Hemorrhage; Postoperative Period; Randomized Controlled Trials as Topic; Treatment Outcome | 2020 |
1 trial(s) available for acebutolol and Blood Loss, Surgical
| Article | Year |
|---|---|
The Important Role for Intravenous Iron in Perioperative Patient Blood Management in Major Abdominal Surgery: A Randomized Controlled Trial.
Topics: Abdominal Cavity; Aged; Anemia, Iron-Deficiency; Blood Loss, Surgical; Blood Transfusion; Body Mass Index; Digestive System Surgical Procedures; Female; Ferric Compounds; Follow-Up Studies; Humans; Injections, Intravenous; Length of Stay; Male; Maltose; Middle Aged; Perioperative Care; Postoperative Care; Quality of Life; Treatment Outcome | 2016 |
3 other study(ies) available for acebutolol and Blood Loss, Surgical
| Article | Year |
|---|---|
Preoperative Intravenous Iron in Anemic Patients Undergoing Major Abdominal Surgery May Not PREVENTT Blood Transfusions But Still Contribute to the Objectives of Patient Blood Management.
Topics: Abdomen; Administration, Intravenous; Anemia; Biomarkers; Blood Loss, Surgical; Blood Transfusion; Drug Administration Schedule; Ferric Compounds; Hematinics; Hemoglobins; Humans; Maltose; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome | 2021 |
Patient Blood Management in Major Orthopedic Surgery: Less Erythropoietin and More Iron?
Topics: Aged; Aged, 80 and over; Anemia; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Biomarkers; Blood Loss, Surgical; Blood Transfusion; Drug Administration Schedule; Drug Compounding; Erythropoietin; Female; Ferric Compounds; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Injections, Subcutaneous; Male; Maltose; Middle Aged; Program Evaluation; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2017 |
Postoperative Intravenous Ferric Carboxymaltose Reduces Transfusion Amounts after Orthopedic Hip Surgery.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Blood Loss, Surgical; Blood Transfusion; Female; Ferric Compounds; Hemoglobins; Hip Joint; Humans; Length of Stay; Male; Maltose; Middle Aged; Postoperative Care; Postoperative Complications; Propensity Score; Retrospective Studies; Young Adult | 2018 |